Selected research
Industry Research
Steroids APIs Industry Research Report 2026
Market perspective
The global Steroids APIs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Steroids APIs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Steroids APIs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Steroids APIs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Steroids APIs include Teva, Sanofi, Merck, Pfizer, Hubei Gedian, Henan Lihua, GSK, Bayer and Symbiotec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Steroids APIs market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Steroids APIs Market by Company
Teva
Sanofi
Merck
Pfizer
Hubei Gedian
Henan Lihua
GSK
Bayer
Symbiotec
Olon
Lupin
Ipca Laboratories
Cipla
Cambrex
Axplora
Aspen API
Steroids APIs Segment by Type
Corticosteroids APIs
Sex Hormone Steroids APIs
Steroids APIs Segment by Application
Veterinary Medicine
Human Pharmaceuticals
Others
Steroids APIs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Steroids APIs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Steroids APIs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Steroids APIs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Steroids APIs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Steroids APIs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Steroids APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Corticosteroids APIs
- Sex Hormone Steroids APIs
Applications
- Veterinary Medicine
- Human Pharmaceuticals
- Others
Companies covered
- Teva
- Sanofi
- Merck
- Pfizer
- Hubei Gedian
- Henan Lihua
- GSK
- Bayer
- Symbiotec
- Olon
- Lupin
- Ipca Laboratories
- Cipla
- Cambrex
- Axplora
- Aspen API
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Steroids APIs Market Size (2021-2032)
- 2.2.2 Global Steroids APIs Sales (2021-2032)
- 2.2.3 Global Steroids APIs Market Average Price (2021-2032)
- 2.3 Steroids APIs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Corticosteroids APIs
- 2.3.3 Sex Hormone Steroids APIs
- 2.4 Steroids APIs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Veterinary Medicine
- 2.4.3 Human Pharmaceuticals
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Steroids APIs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Steroids APIs Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Steroids APIs Revenue of Manufacturers (2021-2026)
- 3.4 Global Steroids APIs Average Price by Manufacturers (2021-2026)
- 3.5 Global Steroids APIs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Steroids APIs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Steroids APIs, Product Type & Application
- 3.8 Global Manufacturers of Steroids APIs, Established Date
- 3.9 Global Steroids APIs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Teva
- 4.1.1 Teva Company Information
- 4.1.2 Teva Business Overview
- 4.1.3 Teva Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Teva Steroids APIs Product Portfolio
- 4.1.5 Teva Recent Developments
- 4.2 Sanofi
- 4.2.1 Sanofi Company Information
- 4.2.2 Sanofi Business Overview
- 4.2.3 Sanofi Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sanofi Steroids APIs Product Portfolio
- 4.2.5 Sanofi Recent Developments
- 4.3 Merck
- 4.3.1 Merck Company Information
- 4.3.2 Merck Business Overview
- 4.3.3 Merck Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merck Steroids APIs Product Portfolio
- 4.3.5 Merck Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Steroids APIs Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Hubei Gedian
- 4.5.1 Hubei Gedian Company Information
- 4.5.2 Hubei Gedian Business Overview
- 4.5.3 Hubei Gedian Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hubei Gedian Steroids APIs Product Portfolio
- 4.5.5 Hubei Gedian Recent Developments
- 4.6 Henan Lihua
- 4.6.1 Henan Lihua Company Information
- 4.6.2 Henan Lihua Business Overview
- 4.6.3 Henan Lihua Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Henan Lihua Steroids APIs Product Portfolio
- 4.6.5 Henan Lihua Recent Developments
- 4.7 GSK
- 4.7.1 GSK Company Information
- 4.7.2 GSK Business Overview
- 4.7.3 GSK Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 GSK Steroids APIs Product Portfolio
- 4.7.5 GSK Recent Developments
- 4.8 Bayer
- 4.8.1 Bayer Company Information
- 4.8.2 Bayer Business Overview
- 4.8.3 Bayer Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Bayer Steroids APIs Product Portfolio
- 4.8.5 Bayer Recent Developments
- 4.9 Symbiotec
- 4.9.1 Symbiotec Company Information
- 4.9.2 Symbiotec Business Overview
- 4.9.3 Symbiotec Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Symbiotec Steroids APIs Product Portfolio
- 4.9.5 Symbiotec Recent Developments
- 4.10 Olon
- 4.10.1 Olon Company Information
- 4.10.2 Olon Business Overview
- 4.10.3 Olon Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Olon Steroids APIs Product Portfolio
- 4.10.5 Olon Recent Developments
- 4.11 Lupin
- 4.11.1 Lupin Company Information
- 4.11.2 Lupin Business Overview
- 4.11.3 Lupin Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Lupin Steroids APIs Product Portfolio
- 4.11.5 Lupin Recent Developments
- 4.12 Ipca Laboratories
- 4.12.1 Ipca Laboratories Company Information
- 4.12.2 Ipca Laboratories Business Overview
- 4.12.3 Ipca Laboratories Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Ipca Laboratories Steroids APIs Product Portfolio
- 4.12.5 Ipca Laboratories Recent Developments
- 4.13 Cipla
- 4.13.1 Cipla Company Information
- 4.13.2 Cipla Business Overview
- 4.13.3 Cipla Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Cipla Steroids APIs Product Portfolio
- 4.13.5 Cipla Recent Developments
- 4.14 Cambrex
- 4.14.1 Cambrex Company Information
- 4.14.2 Cambrex Business Overview
- 4.14.3 Cambrex Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 Cambrex Steroids APIs Product Portfolio
- 4.14.5 Cambrex Recent Developments
- 4.15 Axplora
- 4.15.1 Axplora Company Information
- 4.15.2 Axplora Business Overview
- 4.15.3 Axplora Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Axplora Steroids APIs Product Portfolio
- 4.15.5 Axplora Recent Developments
- 4.16 Aspen API
- 4.16.1 Aspen API Company Information
- 4.16.2 Aspen API Business Overview
- 4.16.3 Aspen API Steroids APIs Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Aspen API Steroids APIs Product Portfolio
- 4.16.5 Aspen API Recent Developments
5 Global Steroids APIs Market Scenario by Region
- 5.1 Global Steroids APIs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Steroids APIs Sales by Region: 2021-2032
- 5.2.1 Global Steroids APIs Sales by Region: 2021-2026
- 5.2.2 Global Steroids APIs Sales by Region: 2027-2032
- 5.3 Global Steroids APIs Revenue by Region: 2021-2032
- 5.3.1 Global Steroids APIs Revenue by Region: 2021-2026
- 5.3.2 Global Steroids APIs Revenue by Region: 2027-2032
- 5.4 North America Steroids APIs Market Facts & Figures by Country
- 5.4.1 North America Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Steroids APIs Sales by Country (2021-2032)
- 5.4.3 North America Steroids APIs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Steroids APIs Market Facts & Figures by Country
- 5.5.1 Europe Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Steroids APIs Sales by Country (2021-2032)
- 5.5.3 Europe Steroids APIs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Steroids APIs Market Facts & Figures by Country
- 5.6.1 Asia Pacific Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Steroids APIs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Steroids APIs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Steroids APIs Market Facts & Figures by Country
- 5.7.1 South America Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Steroids APIs Sales by Country (2021-2032)
- 5.7.3 South America Steroids APIs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Steroids APIs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Steroids APIs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Steroids APIs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Steroids APIs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Steroids APIs Sales by Type (2021-2032)
- 6.1.1 Global Steroids APIs Sales by Type (2021-2032) & (t)
- 6.1.2 Global Steroids APIs Sales Market Share by Type (2021-2032)
- 6.2 Global Steroids APIs Revenue by Type (2021-2032)
- 6.2.1 Global Steroids APIs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Steroids APIs Revenue Market Share by Type (2021-2032)
- 6.3 Global Steroids APIs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Steroids APIs Sales by Application (2021-2032)
- 7.1.1 Global Steroids APIs Sales by Application (2021-2032) & (t)
- 7.1.2 Global Steroids APIs Sales Market Share by Application (2021-2032)
- 7.2 Global Steroids APIs Revenue by Application (2021-2032)
- 7.2.1 Global Steroids APIs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Steroids APIs Revenue Market Share by Application (2021-2032)
- 7.3 Global Steroids APIs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Steroids APIs Value Chain Analysis
- 8.1.1 Steroids APIs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Steroids APIs Production Mode & Process
- 8.2 Steroids APIs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Steroids APIs Distributors
- 8.2.3 Steroids APIs Customers
9 Global Steroids APIs Analyzing Market Dynamics
- 9.1 Steroids APIs Industry Trends
- 9.2 Steroids APIs Industry Drivers
- 9.3 Steroids APIs Industry Opportunities and Challenges
- 9.4 Steroids APIs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst